Filter
72
Text search:
cutaneous
leishmaniasis
(CL)
Featured
Recommendations
8
New Publications
7
Language
Document type
Studies & Reports
19
No document type
17
Resource Platforms
8
Guidelines
8
Videos
7
Fact sheets
4
Infographics
3
Manuals
2
Training Material
2
Strategic & Response Plan
2
Countries / Regions
Global
26
Ethiopia
9
Latin America and the Carribbean
9
India
3
Nepal
3
Kenya
3
Sudan
3
Brazil
3
Somalia
2
South Sudan
2
Bangladesh
2
Middle East and North Africa
2
Africa
2
Morocco
1
Saudi Arabia
1
Uganda
1
Pakistan
1
Iraq
1
Jordan
1
Germany
1
Lebanon
1
Turkey
1
Syria
1
China
1
Colombia
1
Greece
1
South–East Asia Region
1
Western and Central Europe
1
Paraguay
1
Asia
1
Eastern Europe
1
Albania
1
Iran
1
Georgia
1
Tunisia
1
Authors & Publishers
Publication Years
Category
Countries
18
Clinical Guidelines
11
Public Health
8
Key Resources
2
Women & Child Health
1
Pharmacy & Technologies
1
Toolboxes
NTDs
49
Planetary Health
2
Ebola
1
Refugee
1
HIV
1
COVID-19
1
Pharmacy
1
An interregional meeting on leishmaniasis among neighbouring endemic
countries in the Eastern Mediterranean, African and European regions was organized by the World Health Organization (WHO) Regional Office for the Eastern
Mediterranean in Amman,
...
This publication represents a key step forward in translating Control of the leishmaniases (WHO Technical Report Series, No. 949) into a more practical tool for health personnel directly involved in the case management of cutaneous
...
In the Region of the Americas, the leishmaniases are a group of diseases caused by various species of Leishmania, which cause a set of clinical syndromes in infected humans that can involve the skin, mucosa, and visceral organs. The spectrum of clinical disease is varied and depends on the interacti
...
2nd edition. These guidelines include several notable changes from the first edition. For cutaneous leishmaniasis, ketoconazole has been removed from the list of treatment options; the number of Lei
...
This technical report presents the epidemiology of human and animal leishmaniases in the EU and its neighbouring countries and concludes that the disease remains widespread and underreported in many countries of southern Europe, northern Africa, and the Middle East and that there is a need to improv
...
2nd edition
J Glob Health Sci. 2020 Jun;2(1):e3. A group of enzootic and zoonotic protozoan infections, the leishmaniases constitute among the most severely neglected tropical diseases (NTDs) and are found in all continents except Oceania. Representing the most common infectious diseases, NTDs comprise an open-
...
This report provides a review and analysis of the research landscape for three diseases – Chagas disease, human African trypanosomiasis and leishmaniasis – that disproportionately afflict poor and remote populations with limited access to health
...
Front Chem. 2021; 9: 622286.
Published online 2021 Mar 12. doi: 10.3389/fchem.2021.622286
Despite the significant role of vector control in national leishmaniasis control programmes, the programmatic community perceives vector control as the weakest component of leishmaniasis control str
...
This report on global leishmaniasis surveillance follows those published in 2016–2023.2–6 Six indicators of leishmaniasis are publicly available from the Global Health Observatory (GHO).7 In add
...
Leishmaniasis is a complex vector-borne disease involving in its transmission several species of protozoan parasites called Leishmania, a wide variety of animal reservoirs and phlebotomine sandflies vectors.
...
Localized cutaneous leishmaniasis and its evolving forms (diffuse cutaneous leishmaniasis, mucos
...
We reviewed the evidence on community-based interventions for the prevention and control of cutaneous leishmaniasis (CL). Community initiatives tai
...
Cutaneous leishmaniasis (CL) is a neglected infectious endemic disease that is transmitted through the bite of a vector insect (sandfly) of the Lut
...
Leitlinie der Deutschen Gesellschaft für Tropenmedizin und Internationale Gesundheit (DTG) in Zusammenarbeit mit der Paul-Ehrlich-Gesellschaft für Chemotherapie (PEG) und der Deutschen Dermatologischen Gesellschaft
Cutaneous Leishmaniasis (CL) is a painful disease that exerts a serious toll on societies around the world that are afflicted by it. Although not l
...
The skin of a patient is the first and most visible structure of the body that any health-care worker encounters during the course of an examination. To the patient, it is also highly visible, and any disease that affects it is noticeable and will have an impact on personal and social well-being. Th
...
Leishmaniasis is a parasitic disease that is found in parts of the tropics, subtropics, and southern Europe. Leishmaniasis is caused by infection with Leishmania parasites, which are spread by the b
...
Cutaneous leishmaniasis (CL) is a parasitic disease caused by infection with a vector-borne protozoan parasite of the genus Leishmania spp. The par
...
